Home Online Features FDA declares Wegovy® and Ozempic® shortage is over and that Novo Nordisk is fully meeting or exceeding nationwide demand for all doses
FDA declares Wegovy® and Ozempic® shortage is over and that Novo Nordisk is fully meeting or exceeding nationwide demand for all doses
Press Releases
Novo Nordisk Inc.  
February 21, 2025

FDA declares Wegovy® and Ozempic® shortage is over and that Novo Nordisk is fully meeting or exceeding nationwide demand for all doses

All doses of the only real FDA-approved semaglutide medicines are being continuously shipped, meeting or exceeding expected U.S. demand FDA's decision means that making or selling a knockoff compounded drug

avatar profile Olean Times Herald

Olean Times Herald

email Olean Times Herald

Local & Social